Who owns UNICYCIVE THERAPEUTICS INC?
- Ticker: UNCY
- CUSIP Number: 90466y202
Tip: Access positions for across all investors
Analyze quarterly positions in Unicycive Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Unicycive Therapeutics stock
Who bought or sold UNICYCIVE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vivo Capital | 1.8M | $12M | 0% | Mar 2026 |
|
| Millennium Management | 1.4M | $9.2M | 38% | Mar 2026 |
|
| Octagon Capital Advisors | 1.0M | $6.6M | 0% | Mar 2026 |
|
| Nantahala Capital Management | 939k | $6.2M | 0% | Mar 2026 |
|
| Vanguard Capital Management | 811k | $5.3M | 100% | Mar 2026 |
|
| Dr. Jeffrey R. Jay, M.D. | 797k | $5.2M | 0% | Mar 2026 |
|
| Vanguard Group | 789k | $4.6M | 20% | Dec 2025 |
|
| Logos Global Management | 474k | $3.1M | 0% | Mar 2026 |
|
| Citadel Advisors | 345k | $2.3M | 28% | Mar 2026 |
|
| Geode Capital Management | 204k | $1.3M | 19% | Mar 2026 |
|
| Morgan Stanley | 188k | $1.2M | 304% | Mar 2026 |
|
| Jane Street | 156k | $1.0M | 647% | Mar 2026 |
|
| Dimensional Fund Advisors | 143k | $941k | 100% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 120k | $787k | 20% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 101k | $665k | 100% | Mar 2026 |
|
| Dauntless Investment Group | 89k | $516k | 100% | Dec 2025 |
|
| Diametric Capital | 80k | $529k | 100% | Mar 2026 |
|
| Cantor Fitzgerald, L. P. | 75k | $494k | -62% | Mar 2026 |
|
| State Street Corporation | 65k | $376k | 19% | Dec 2025 |
|
| Longwood Capital Partners | 58k | $381k | -3% | Mar 2026 |
|
| Seven Fleet Capital Management | 56k | $367k | 100% | Mar 2026 |
|
| Susquehanna International | 51k | $296k | 100% | Dec 2025 |
|
| Hrt Financial | 42k | $273k | 100% | Mar 2026 |
|
| Quadrature Capital | 39k | $226k | 100% | Dec 2025 |
|
| Northern Trust | 36k | $207k | 10% | Dec 2025 |
|
| BlackRock | 36k | $236k | -1% | Mar 2026 |
|
| XTX Topco | 35k | $204k | -6% | Dec 2025 |
|
| OMERS Administration Corporation | 32k | $210k | -59% | Mar 2026 |
|
| Bank of America Corporation | 30k | $194k | 100% | Mar 2026 |
|
| Goldman Sachs Group | 27k | $178k | 100% | Mar 2026 |
|
| Persistent Asset Partners | 27k | $177k | 100% | Mar 2026 |
|
| Chicago Partners Investment | 22k | $168k | -3% | Mar 2026 |
|
| UBS Group | 19k | $128k | -2% | Mar 2026 |
|
| Vanguard Global Advisers | 7.9k | $52k | 100% | Mar 2026 |
|
| Tower Research Capital | 1.9k | $11k | 100% | Dec 2025 |
|
| Rockefeller Capital Management | 1.6k | $11k | 220% | Mar 2026 |
|
| SBI Securities | 557.00 | $3.7k | 0% | Mar 2026 |
|
| Royal Bank of Canada | 377.00 | $0 | 100% | Mar 2026 |
|
| TFC Financial Management | 300.00 | $2.0k | 0% | Mar 2026 |
|
| Harbour Investments | 100.00 | $658.000000 | 0% | Mar 2026 |
|
| Barclays | 80.00 | $462.000000 | 0% | Dec 2025 |
|
| Fortitude Family Office | 75.00 | $494.002500 | 100% | Mar 2026 |
|
| Bogart Wealth | 6.00 | $39.000000 | 0% | Mar 2026 |
|
| Caitong International Asset Management | 5.00 | $33.000000 | 100% | Mar 2026 |
|
| Citigroup | 1.00 | $7.000000 | 100% | Mar 2026 |
|
| Danske Bank A/s | 1.00 | $7.000000 | 0% | Mar 2026 |
|
Who sold out of Unicycive Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Squarepoint Ops | Dec 2025 | 55k | $319k |